Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cold (non-thermal) plasma to improve healing and reduce complications after thyroid removal

Official title: Evaluation of Non-Thermal Plasma as an Innovative Strategy for Optimizing Post-Surgical Wound Treatment in Patients of Thyroid Surgery: An Ethical and Clinical Approach

Run by National Institute of Nuclear Research - Mexico · NCT07382973 · Data updated 2026-11-12

This will test whether applying helium-based non-thermal (cold) plasma during total thyroidectomy helps wounds heal faster and reduces pain, inflammation, and infections in adults having their thyroid removed.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment26 (estimated)
SponsorNational Institute of Nuclear Research - Mexico
Academic / other
Drugs / interventionsradiation
Locations1 site (Ocoyoacac, State of Mexico)
StatusRecruiting
StartedAugust 20, 2025
Main results expectedSeptember 30, 2026
Study endsDecember 30, 2026
Registry record updatedNovember 5, 2026
Trial IDNCT07382973 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for total or subtotal thyroidectomy who can attend a 12-week follow-up and who have no prior neck surgery or radiation, no implanted electronic devices, are not pregnant or breastfeeding, and are not on systemic immunosuppressants.

Probably not a fit

Patients with prior neck surgery or radiation, active infection, keloid-prone scarring, implanted pacemakers/defibrillators, pregnancy, breastfeeding, or current systemic corticosteroid/immunosuppressive use are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional pilot compares intraoperative helium-based non-thermal plasma (NTP) plus standard wound care versus standard wound care alone in adults undergoing total or subtotal thyroidectomy. The NTP protocol is applied in two phases: an 8–10 minute exposure to the surgical bed for hemostasis and neuroprotection, with an additional 10–12 minute exposure to resection micro-margins when incidental malignancy is suspected. The device generates reactive oxygen and nitrogen species (RONS) at low temperature to promote decontamination and tissue repair while minimizing thermal damage to nerves and parathyroid glands. Participants are followed for 12 weeks to track wound healing, pain, infections, and safety outcomes related to cervical neurovascular structures.

Why it matters

Potential benefit: If successful, NTP could lower postoperative wound complications, reduce pain and inflammation, and selectively reduce microscopic residual tumor without causing thermal injury to nearby nerves or glands.

How similar studies have gone: Preclinical work and early clinical reports suggest NTP can aid wound decontamination and healing, but its intraoperative use as an adjuvant in thyroid surgery is novel and not yet widely validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years or older.
* Diagnosis of thyroid pathology requiring total or subtotal thyroidectomy.
* Signed Informed Consent Form (ICF).
* Patients capable of complying with the 12-week follow-up schedule.

Exclusion Criteria:

* History of previous neck surgery or radiation therapy in the cervical area.
* Known history of keloid formation or hypertrophic scarring.
* Presence of active systemic or local infection at the time of surgery.
* Patients with implanted electronic devices (e.g., pacemakers or defibrillators) due to the use of RF-based plasma.
* Pregnancy or breastfeeding.
* Concurrent use of systemic corticosteroids or immunosuppressive drugs that may impair wound healing.

Where it's running

  • Plasma Physics Laboratory, National Institute of Nuclear Research
    Ocoyoacac, State of Mexico, Mexico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.